EIGER BIOPHARMACEUTICALS INC (EIGRQ)
Institutional ownership reported to the SEC as of Q2 2025, across 19 quarters.
1
Reporting holders
$423.0K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Propel Bio Management, LLC | $423.0K | 146,381 | 0.51% | 6q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2025 | 1 | $423.0K | 146,381 | 0 | 0 | 0 | 0.0% |
| Q1 2025 | 1 | $423.0K | 146,381 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 1 | $765.0K | 146,381 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 1 | $1.2M | 146,381 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 2 | $1.9M | 146,424 | 0 | 0 | 1 | 0.0% |
| Q1 2024 | 22 | $3.1M | 655,381 | 22 | 0 | 0 | 0.0% |
| Q2 2023 | 2 | $11.7K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2023 | 2 | $24.3K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2022 | 2 | $8.6K | 0 | 1 | 0 | 0 | 100.0% |
| Q3 2022 | 2 | $41.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2022 | 2 | $23.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2022 | 2 | $907.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q4 2021 | 2 | $26.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2021 | 2 | $682.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2021 | 2 | $2.1M | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2021 | 2 | $1.3M | 0 | 2 | 0 | 0 | 100.0% |
| Q4 2020 | 1 | $211.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2020 | 2 | $15.0K | 0 | 4 | 0 | 0 | 100.0% |
| Q4 2019 | 1 | $7.0K | 0 | 1 | 0 | 0 | 100.0% |